Artificial Intelligence
Empowering Pharmaceutical Companies in Chronic Disease Research and Identifying Unmet Needs says Disease Landscape Insights
Chronic diseases are long term ailments that progress over time. They are non-communicable in nature and can lead to severe health complications if left undetected and untreated. Chronic disease prevalence has been increasing dramatically across the globe. Unhealthy lifestyle choices, rise in the geriatric populace, environmental degradation, genetic issues, and inadequate access to quality healthcare services are some of the major factors leading to the onset of long term illness in individuals.
There is a wide range of chronic diseases affecting millions of people worldwide. Such ailments might start developing at an early age with intended affects in later years. Effective management of such ailments involve early diagnosis, accurate medical intervention, lifestyle changes, and constant monitoring, among others. Healthcare professionals including researchers and physicians along with pharma leaders are constantly involve in R&D activities with an aim to find effective diagnostic and treatment solutions for the same. World Health Organization’s chronic disease statistics 2023 denotes that long terms ailments account for 41% million deaths each year. This rate is projected to soar in the coming years.
Disease Landscape Insights has been offering healthcare consulting services to these players with an aim to enhance their understanding on chronic disorders. It boasts a comprehensive portfolio of chronic disease research documents, encompassing a wide spectrum of ailments such as anemia, diabetes, stroke, obesity, arthritis, heart diseases, and more. Within DLI’s extensive repository, these documents serve as a valuable resource, providing deep dive insights into the complexities of chronic ailments. Through DLI’s advanced platform, chronic disease market players and stakeholders gain access to a wealth of knowledge that empowers them to make well-informed decisions.
Chronic Diseases- Characteristics, Symptoms and Implications
A significant portion of the world population is living with chronic disease. The characteristics and traits of these ailments are distinct. But most of these diseases are long lasting, highly complexed, non-transmissible, and progressive. Apart from that, some of the common symptoms triggered by all chronic ailments are fatigue, sudden weight fluctuation, frequent infections, and digestive issues, among others.
The proper identification of these symptoms is crucial for healthcare professionals to diagnose the potential ailment. It is worth noting that most incurable disease including chronic ones can be regulated with proper medical intervention. DLI has been assisting players in their chronic disease assessment so that they can expedite their therapy or drug development process.
Elucidating the treatment scenario
Chronic disease treatment vertical is vast, encompassing drugs, therapies, surgical interventions, and lifestyle changes, among others. Medication adherence in chronic disease is crucial because of its progressive nature. The prescribed medicines are required to be consumed by patients to manage the symptoms and slow down the disease progress. The chronic disease management market has been gaining massive traction over the years. This is due to the increased health cognizance of the masses along with the elevating demand for highly effective treatment solutions.
Here is an overview of the chronic disease management outlook-
Lifestyle Modifications: Encouraging patients to adopt a healthy diet, exercise regularly, manage stress, and avoid smoking and excessive alcohol consumption is a common approach for many chronic diseases.
Medications: Depending on the specific chronic disease, medications may include antibiotics for chronic infections, antihypertensive drugs for high blood pressure, insulin or oral medications for diabetes, or anti-inflammatory drugs for conditions like arthritis.
Physical Therapy: Physical therapy can help manage chronic pain and improve mobility and function in conditions like osteoarthritis or chronic back pain.
Dietary Management: Dietary changes are often recommended to control chronic diseases, such as reducing sodium intake for hypertension, following a low-sugar diet for diabetes, or a low-fat diet for heart disease.
Regular Monitoring: Routine monitoring of vital signs, blood glucose levels, or other relevant markers is crucial for managing many chronic diseases.
Supportive Care: Supportive care, including palliative care and symptom management, may be necessary for advanced chronic conditions, such as cancer.
Medication Adherence: Ensuring that patients adhere to their prescribed medication regimens is vital for managing chronic diseases effectively.
Education: Providing patients with information about their condition, its management, and potential complications is essential for empowering them to take control of their health.
Surgery: In some cases, surgical interventions, such as joint replacement for osteoarthritis or coronary artery bypass surgery for advanced heart disease, may be necessary.
Mental Health Support: Managing the psychological aspects of living with a chronic disease often involves counseling or therapy to address depression, anxiety, or stress.
It is worth mentioning that the treatment plans may completely vary based on the disease type, overall health status of the patients, along with other physiological and psychological aspects.
DLI’s Extended Role in Clinical Trial Assessment
Chronic disease epidemiology study extensively conducted by DLI suggests highlight the importance of early detection and screening which in turn paves the way for real time medical intervention. It is worth noting that medical researchers and chronic disease pharmacies/pharma leaders are working efficiently to develop favourable chronic disease products that can enhance the quality of life of the patients.
But in order to get these potential products including drugs and therapies approved for commercial use, they are required to undergo a strenuous chronic disease clinical trials process. DLI has been a constant support for these players during this phase. Clinical trials are a complicated process wherein the participants are required to take care of multiple things simultaneously. Any sort of negligence may hinder the entire process. DLI through its expertise in this domain has been involved in safety monitoring, data analysis, efficacy assessment, data review, participant protection, and chronic disease regulatory compliance. By offering these services, it has helped the players ensure the real time and successful completion of the clinical trial rounds.
Post successful trials, the next step for players is to launch their products. DLI equips them with in depth product launch services and drug launch strategies, enabling them to gain market access while strengthening their market position.
Post Launch Scenario
After the drug or therapy gets approval for commercial use and is launched in the market, the players starting formulating strategies that can help their products to make huge profits. For that, they ensure if their products are showing promising results. They do so by gathering and analysing customer insights. Many players seek consulting services in their post launch phase. DLI has been successfully empowering these players with product portfolio analysis, commercial strategy analysis, pricing and reimbursement-based data, along with product portfolio extension tactics.
Final Words
The increased pervasiveness of chronic diseases is a cause of concern across numerous nations. This has pushed medical researchers and other healthcare professionals to formulate effective chronic disease management solutions. Given the complexed nature of long-term illness, navigating through this journey can be rigorous and time consuming for the players. By collaborating with Disease Landscape Insights, they are being able to expedite their R&D activities. DLI has always been focused on chronic disease medicine reimbursement, in-depth chronic disease analysis, Clinical Trial Feasibility Analysis, and the provision of valuable drug insights signifies a holistic and forward-looking strategy. These strategies aim towards alleviating economical burden for patients while ensuring the efficiency of clinical trials. DLI has joined hands with the chronic disease vertical leaders to redefine landscape of chronic disease management, offering a more comprehensive and patient-centric approach to tackling these challenging medical conditions.
Artificial Intelligence
Aon and Marsh McLennan call on (re)insurance industry to aid Ukraine’s resilience
– The firms emphasized that the removal of blanket exclusions would catalyze Ukraine’s growth and future reconstruction
MONTE CARLO, Sept. 8, 2024 /PRNewswire/ — Aon and Marsh McLennan today called on the (re)insurance industry to build upon the capital, expertise and historical role of the (re)insurance industry to help Ukraine’s resilience by catalyzing economic growth and strengthening the country’s foundations for a post-conflict economy. The firms emphasized that the removal of blanket exclusions, which ignore the diversity of risk throughout the country, would further support for Ukraine’s economy.
Additionally, since the start of the war, many global reinsurers have grouped risks originating in Ukraine, Russia, and Belarus together, excluding them from reinsurance contracts, limiting (re)insurance capital and impeding economic growth and stability. The inclusion of Ukraine with Russia and Belarus is not rooted in the data and analytics that drive the assessment of risk and overlooks that Ukraine, while under siege, seeks to further align as a free and democratic economy and member of the European Union.
“Marsh McLennan is dedicated in our support of Ukraine – helping it attract global investment to rebuild the country, and recover from the devastating impact of war on its people and economy,” said John Doyle, president and CEO of Marsh McLennan. “We call on the global insurance community to join us in this effort and end blanket exclusions for Ukraine.”
“Aon’s support of Ukraine leads us to look forward to its economic recovery,” said Greg Case, CEO of Aon. “Insurance capital is essential for the reconstruction of Ukraine’s health care, energy and agricultural sectors. We’re asking the insurance industry to look closely at Ukraine’s risks and work to strengthen the public private partnerships under development.”
Marsh McLennan and Aon each are already working with the Ukraine, U.S. and UK governments, along with many other international organizations, to support Ukraine’s economy as it endures ongoing attacks and accelerate investment in the country’s eventual economic recovery.
In March, Marsh McLennan announced the expansion of its public-private partnership with the Ukraine government to cover all shipping to and from Ukraine’s ports. This follows Marsh McLennan’s support in helping the Ukraine Government develop its war risk data platform which provides investors and (re)insurers with granular transparent data on the impact of the conflict to date and degree of war risk.
In June, Aon worked with the U.S. International Development Finance Corporation to create a first-of-its-kind insurance program to support war risk policies for businesses operating in Ukraine. The availability of insurance for war risk, especially across health care and agriculture, will stimulate economic expansion and employment, while strengthening the foundation of Ukraine’s economy to support a robust reconstruction.
The firms assert that arbitrary exclusions for Ukraine contribute to confusion about the vastly different levels of risk in the country. As a result, there are potential issues with how (re)insurers underwrite risks between regions directly impacted by the war and many areas of central and western Ukraine which have suffered little to no war damage. The use of data and analytics can enable more impactful insights into where insurance capital can contribute to Ukraine’s reconstruction and further economic growth.
About AonAon plc (NYSE: AON) exists to shape decisions for the better — to protect and enrich the lives of people around the world. Through actionable analytic insight, globally integrated Risk Capital and Human Capital expertise, and locally relevant solutions, our colleagues provide clients in over 120 countries with the clarity and confidence to make better risk and people decisions that protect and grow their businesses.
Follow Aon on LinkedIn, X, Facebook and Instagram. Stay up-to-date by visiting Aon’s newsroom and sign up for news alerts here.
About Marsh McLennanMarsh McLennan (NYSE: MMC) is a global leader in risk, strategy and people, advising clients in 130 countries across four businesses: Marsh, Guy Carpenter, Mercer and Oliver Wyman. With annual revenue of $23 billion and more than 85,000 colleagues, Marsh McLennan helps build the confidence to thrive through the power of perspective. For more information, visit marshmclennan.com, or follow on LinkedIn and X.
Media Contacts
[email protected] (U.S., Canada and Puerto Rico): +1 833 751 8114International: +1 312 381 3024
Marsh McLennanJason [email protected]+44 (0)7733 325 587
Logo – https://mma.prnewswire.com/media/1632623/Aon_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/aon-and-marsh-mclennan-call-on-reinsurance-industry-to-aid-ukraines-resilience-302241050.html
Artificial Intelligence
HONOR Redefines Mobile AI Solutions with PC powered by Snapdragon, on-device AI Agent and AI Deepfake Detection at IFA 2024
HONOR, Qualcomm, and Microsoft Redefine Innovations in Mobile AI
BERLIN, Sept. 7, 2024 /PRNewswire/ — Today at IFA 2024, HONOR unveiled three groundbreaking mobile AI Solutions: AI PC powered by Snapdragon® X Elite platforms, AI Agent and AI Deepfake Detection. The launch was accompanied by a thought-provoking panel discussion featuring HONOR CEO George Zhao; Alex Katouzian, Group GM of MCX at Qualcomm Technologies, Inc.; and Mark Linton, VP of Device Partner Sales at Microsoft. Together, they explored the convergence of AI and Snapdragon technology, discussing how these innovations are shaping the future of mobile AI.
“When it comes to mobile computing, AI is not just a buzzword, it’s a revolution,” commented George Zhao, CEO of HONOR Device Co., Ltd. “At HONOR, we’re committed to working with our partners to deliver powerful AI capabilities and seamless connectivity, while protecting our users’ privacy. Through open collaboration with industry leaders, we’re creating devices that empower individuals and redefine what’s possible.”
“At Qualcomm Technologies, we believe the NPU is the key to unlocking the true potential of AI in PCs,” added Alex Katouzian, Group GM of MCX, Qualcomm Technologies, Inc. “The Snapdragon X Elite with its industry-leading NPU performance empowers AI PCs like the HONOR MagicBook Art 14 to deliver next-generation AI experiences. Not only will users see a significant boost in capabilities, but the NPU’s efficiency also translates to longer battery life, allowing users to stay productive for extended periods.”
HONOR MagicBook Art 14 Snapdragon: Redefining PC in the Mobile AI EraThe PC landscape is undergoing a radical transformation, driven by advancements in AI and the rise of Snapdragon platforms. Fueled by HONOR’s platform-level AI capabilities and developed in collaboration with top industry leaders, HONOR MagicBook Art 14 Snapdragon heralds a new era of computing.
Featuring a sleek and compact design, the HONOR MagicBook Art 14 Snapdragon is a marvel of lightweight engineering. It incorporates cutting-edge platform-level AI features alongside robust hardware and software solutions, ensuring unmatched productivity and user experience. It translates the lightweight and slim characteristics of smartphones to laptops, delivering the lightest and slimmest AI PC on the market, weighing approximately 1kg with a slimness of 1cm. Delivering an immersive visual journey, the HONOR MagicBook Art 14 Snapdragon features a captivating 14.6-inch HONOR FullView Touch Display boasting a crystal-clear 3.1K resolution. It also includes an outstanding 97% screen-to-body ratio, the largest among 14-inch laptops. The HONOR MagicBook Art 14 Snapdragon is powered by the Qualcomm Snapdragon X Elite, elevating the computing experience to new heights in terms of power, efficiency, and security.
The HONOR MagicBook Art 14 Snapdragon also enables a smooth transition of Windows applications on X86 to the Windows on Snapdragon architecture. Based on years of research on the ecosystem, HONOR created a Hotspot Library that uses platform-level AI to identify frequently used scenarios and trigger translation optimization efficiently. HONOR has improved 16% of the average boot-up time1 with translation optimization across a diverse array of Windows applications. Currently, HONOR has optimized a total of the Top 14 applications across six major categories, including browsers, online meetings, media, office, social software and tools.
The HONOR MagicBook Art 14 Snapdragon will be soon available in German, France and Italy. For preorder, please visit HONOR online store now at www.honor.com.
Seamless AI Experiences Elevated by the Power of MagicRingIn the mobile AI era, seamless cross-OS connectivity will truly empower users to unlock AI everywhere. Unlike the manual point-to-point connections in traditional solutions, the HONOR MagicRing allows multiple devices of the same account to automatically connect with low power consumption.
The MagicRing not only connects devices but also connects services across the devices. The solution also enables users to use the same set of keyboard and mouse for multiple devices, receive calls and notifications on a device other than their smartphones, and control the smartphone’s camera on the PC. With the secure and smooth flow of services and information across devices, MagicRing makes multi-device AI experience easier. For example, as one of the typical scenarios of Windows on Snapdragon experience, Cocreator allows users to produce fantastic artwork with simple draws. Powered by MagicRing, users can seamlessly access Cocreator on their HONOR MagicPad 2, drawing AI masterpieces with their Magic-Pencil. In the Meanwhile, they can also use AI Eraser from HONOR Magic V3 on the HONOR MagicBook Art 14 Snapdragon to experience unparalleled levels of convenient mobile AI.
HONOR AI Agent: The First On-device AI Agent for the Open Ecosystem The HONOR AI Agent is a revolutionary always-on personal assistant designed to enhance and simplify users’ daily lives. By intuitively understanding users’ requests and intentions through language analysis and UI awareness technology, the AI Agent that learns from their habits and device environment can intelligently make decisions across various apps and services. This capability allows it to automate complex tasks. HONOR demonstrated how to find and cancel unwanted app subscriptions across different apps with just a few simple voice commands on their smartphones.
As we look to the future, the HONOR AI Agent is poised to become the cornerstone of mobile AI, and it is anticipated to arrive with the HONOR Magic7 Series later this year in China. This innovation not only signifies a leap in technology but also heralds a new era where AI seamlessly integrates into our daily routines, enhancing everyday productivity and efficiency.
The World’s First On-device AI Deepfake Detection TechnologyAs the technology behind deepfakes becomes more sophisticated, the potential for misuse, including identity theft and the spread of disinformation, grows significantly. HONOR’s on-device AI Deepfake Detection represents a groundbreaking solution designed to protect users from the increasingly prevalent threat of deepfakes. This innovative detection system employs advanced algorithms to meticulously analyze various elements, including pixel-level synthetic imperfections, border compositing artifacts, inter-frame continuity, consistency in face-to-ear hairstyle, and the positioning of synthetic traces. By examining these characteristics, the technology can accurately identify manipulated content, distinguishing between genuine media and deceptive alterations.
About HONOR HONOR is a leading global provider of smart devices. It is dedicated to becoming a global iconic technology brand and creating a new intelligent world for everyone through its powerful products and services. With an unwavering focus on R&D, it is committed to developing technology that empowers people around the globe to go beyond, giving them the freedom to achieve and do more. Offering a range of high-quality smartphones, tablets, laptops and wearables to suit every budget, HONOR’s portfolio of innovative, premium and reliable products enable people to become a better version of themselves.
For more information, please visit HONOR online at www.honor.com or email [email protected]
https://community.honor.com/ https://www.facebook.com/honorglobal/ https://twitter.com/Honorglobal https://www.instagram.com/honorglobal/ https://www.youtube.com/c/HonorOfficial
1Data comes from HONOR labs.
View original content:https://www.prnewswire.co.uk/news-releases/honor-redefines-mobile-ai-solutions-with-pc-powered-by-snapdragon-on-device-ai-agent-and-ai-deepfake-detection-at-ifa-2024-302241211.html
Artificial Intelligence
TECNO Pocket Go Wins Global Product Technology Innovation Award 2024 at IFA 2024
BERLIN, Sept. 7, 2024 /PRNewswire/ — One of the largest consumer electronics exhibitions in the world, the 2024 IFA Berlin International Consumer Electronics Show, officially kicks off today in Berlin. During the event, the highly anticipated Global Product Technical Innovation Award 2024 was announced, with TECNO Pocket Go winning the prestigious AR Immersive PC Gaming Experience Innovation Gold Award. This recognition highlights the brilliance of Chinese brand on the global stage.
TECNO is dedicated to innovation from the user’s perspective, continuously developing products and applications that enhance user experience. Since 2019, TECNO has expanded its AIoT ecosystem, leveraging its mobile technology to introduce innovative smart wearables, business laptops, and other groundbreaking products, all aimed at providing users with a more intelligent TECNO ecosystem experience.
As a global innovative technology brand with operations in over 70 markets, TECNO has been committed to revolutionizing the digital experience in global emerging markets, relentlessly pushing for the perfect integration of contemporary, aesthetic design with the latest technologies. TECNO offers a wide range of AIoT products covering smart wearables, laptops, tablets and smart home products.
Guided by its brand essence of “Stop At Nothing”, TECNO is committed to unlocking the best and newest technologies for forward-looking individuals, inspiring them to never stop pursuing their best selves and their best futures.
The “Global Product Technology Innovation Award” is a grand international selection of global consumer electronics brands. Launched globally every year, it is also one of the most professional and authoritative international exchange, display and cooperation platforms in IFA in the same year to conduct comprehensive review and evaluation of the global consumer electronics industry for the whole year.
TECNO Pocket Go, redefines gaming on the go
TECNO Pocket Go creates a “new gaming paradise” in handheld PC form in AR industry. By seamlessly integrating with the Windows gaming ecosystem and utilizing advanced head tracking technology, it brings an unparalleled 6D immersive experience to users. Featuring a top-tier AMD® Ryzen™ 7 8840HS gaming processor and a laptop level cooling system by rebuilt the structure to compact size with 50% smaller size and 30% lighter weight. Just easy to carry as a smartphone.
Smaller in your palm, Master in your vision
The AR Pocket Vision features a 0.71-inch Micro-OLED screen that delivers the equivalent of a 215-inch TV experience from 6 meters away, surpassing industry standards. Gamers will enjoy a cinematic-level viewing experience, with customizable adjustments for up to 600° diopters to ensure eye comfort. It also safeguards your privacy, enabling you to play anywhere.
Dominant Flagship Gaming CPU, lead Performance Ahead
Powered by the AMD® Ryzen™ 7 8840HS gaming processor, the Pocket Go handheld offers exceptional speed and seamless multitasking with 8 cores, 16 threads, and turbo speeds up to 5.1 GHz. Its PC-level cooling system, featuring a large fan and three copper pipes, ensures optimal performance at 35W. Combined with a 50Wh replaceable battery, it guarantees long-lasting gaming sessions without interruptions.
“VisionTrack” experiences, games come alive
The Pocket Go combo delivers an immersive experience for your eyes and hands. The AR Pocket Vision features a six-axis gyroscope and AI algorithms for precise head tracking, enhancing real-time data collection during gameplay. With N’BASS® acoustic materials and a proprietary vibration algorithm, it translates in-game sounds into nuanced vibrations via handheld while the Hall Effect Joysticks and Triggers provide precise control, elevating your gaming experience with rich visual and tactile sensations.
With TECNO Pocket Go, users can enjoy a futuristic gaming experience, and seamlessly connecting to TECNO’s products in a new forms of AR experiences.
View original content:https://www.prnewswire.co.uk/news-releases/tecno-pocket-go-wins-global-product-technology-innovation-award-2024-at-ifa-2024-302241146.html
-
Artificial Intelligence6 days agoUNLEASHING INNOVATION: STARS OF SCIENCE SEASON 16 BEGINS SOON
-
Artificial Intelligence7 days agoLG PRESENTS NEW APPLIANCE LINEUP WITH INDUSTRY-LEADING ENERGY EFFICIENCY AT IFA 2024
-
Artificial Intelligence4 days agoAltair Names Collaboration Betters the World as Channel Partner for the EMEA Region
-
Artificial Intelligence6 days agoCloud Services Brokerage Market worth $26.2 billion by 2029 – Exclusive Report by MarketsandMarkets™
-
Artificial Intelligence5 days ago
Autonomous Enterprise Market worth $114.0 billion by 2029 – Exclusive Report by MarketsandMarkets™
-
Artificial Intelligence5 days agoAV-Comparatives Identifies Key Cybersecurity Threats for Summer 2024: Fakeshops, Phishing Attacks and Targeting Children
-
Artificial Intelligence6 days agoFlytxt Appoints Vickram Nagi as Senior Vice President and Head of Global Sales
-
Uncategorized6 days agoNew US Consensus Report supports Nevisense
